Skip to main content

Table 3 The incidence of CIP according to GOLD stage in patients with COPD

From: Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease

 

Total

N = 61

Non-CIP (%)

n = 50

CIP (%)

n = 11

P

GOLD

   

0.796

1

20

16 (80.0)

4 (20.0)

 

2

22

19 (86.4)

3 (13.6)

 

3

19

15 (78.9)

4 (21.1)

 

4

0

0 (0)

0 (0)

 
  1. Abbreviations: CIP, checkpoint inhibitors related pneumonitis; COPD, chronic obstructive pulmonary disease; GOLD, chronic obstructive lung disease